XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.88

+0.2%

Nov 25 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: manfredhasler who wrote (14616)	9/16/2000 8:16:16 PM
From: Cacaito	Read Replies (1) of 17367

Manfred, there was no problem with the design, the recruitment of patients in the high mortality category became a logistics nightmare, mainly cause they could not keep expending money. The company did the best, get as much money during the time data was hidden (no problem for me, I sold a little loss at the time, then I wrongly believe baxter involvement as sign of good data, till the fda proved that wrong). The good doctor Goldstein is just doing the usual show after this type of results, only the proxoma group sees that as "The coming fight for the kids" and dare to see it as a based for an investment.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next